JP Morgan Chase’s BioDelivery Sciences International, Inc. BDSI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | – | Sell |
-572,083
| Closed | -$1.77M | – | 7363 |
|
|
2021
Q4 | $1.77M | Sell |
572,083
-42,667
| -7% | -$144K | ﹤0.01% | 3945 |
|
|
2021
Q3 | $2.22M | Sell |
614,750
-138,436
| -18% | -$522K | ﹤0.01% | 3706 |
|
|
2021
Q2 | $2.7M | Buy |
753,186
+532,541
| +241% | +$1.88M | ﹤0.01% | 3573 |
|
|
2021
Q1 | $863K | Buy |
220,645
+49,151
| +29% | +$203K | ﹤0.01% | 4334 |
|
|
2020
Q4 | $721K | Buy |
171,494
+138,042
| +413% | +$532K | ﹤0.01% | 4157 |
|
|
2020
Q3 | $126K | Buy |
33,452
+3,548
| +12% | +$15.1K | ﹤0.01% | 4589 |
|
|
2020
Q2 | $130K | Buy |
29,904
+2,496
| +9% | +$11.2K | ﹤0.01% | 4465 |
|
|
2020
Q1 | $104K | Buy |
27,408
+25
| +0.1% | +$123 | ﹤0.01% | 4503 |
|
|
2019
Q4 | $173K | Hold |
27,383
| – | – | ﹤0.01% | 4727 |
|
|
2019
Q3 | $115K | Sell |
27,383
-293,817
| -91% | -$1.25M | ﹤0.01% | 4849 |
|
|
2019
Q2 | $1.41M | Sell |
321,200
-405,378
| -56% | -$1.89M | ﹤0.01% | 3627 |
|
|
2019
Q1 | $3.85M | Buy |
726,578
+296,665
| +69% | +$1.35M | ﹤0.01% | 2804 |
|
|
2018
Q4 | $1.59M | Buy |
429,913
+162,039
| +60% | +$569K | ﹤0.01% | 3436 |
|
|
2018
Q3 | $750K | Buy |
267,874
+70,633
| +36% | +$198K | ﹤0.01% | 4069 |
|
|
2018
Q2 | $582K | Buy |
+197,241
| New | +$468K | ﹤0.01% | 4106 |
|
|
2018
Q1 | – | Sell |
-53,667
| Closed | -$158K | – | 5841 |
|
|
2017
Q4 | $158K | Buy |
53,667
+14,200
| +36% | +$39.3K | ﹤0.01% | 4508 |
|
|
2017
Q3 | $116K | Buy |
+39,467
| New | +$120K | ﹤0.01% | 4265 |
|
|
2016
Q3 | – | Sell |
-2,305
| Closed | -$5K | – | 5117 |
|
|
2016
Q2 | $5K | Sell |
2,305
-295,228
| -99% | -$815K | ﹤0.01% | 4473 |
|
|
2016
Q1 | $961K | Buy |
297,533
+18,533
| +7% | +$68.5K | ﹤0.01% | 3089 |
|
|
2015
Q4 | $1.34M | Sell |
279,000
-39,294
| -12% | -$223K | ﹤0.01% | 2974 |
|
|
2015
Q3 | $1.77M | Buy |
318,294
+67,702
| +27% | +$500K | ﹤0.01% | 2809 |
|
|
2015
Q2 | $1.99M | Buy |
250,592
+162,465
| +184% | +$1.4M | ﹤0.01% | 2916 |
|
|
2015
Q1 | $926K | Buy |
88,127
+2,277
| +3% | +$31.1K | ﹤0.01% | 3261 |
|
|
2014
Q4 | $1.03M | Sell |
85,850
-5,950
| -6% | -$90.4K | ﹤0.01% | 3327 |
|
|
2014
Q3 | $1.57M | Sell |
91,800
-55,625
| -38% | -$807K | ﹤0.01% | 3076 |
|
|
2014
Q2 | $1.78M | Sell |
147,425
-27,425
| -16% | -$260K | ﹤0.01% | 2599 |
|
|
2014
Q1 | $1.48M | Buy |
174,850
+28,475
| +19% | +$230K | ﹤0.01% | 2693 |
|
|
2013
Q4 | $862K | Sell |
146,375
-3,618
| -2% | -$18.6K | ﹤0.01% | 3217 |
|
|
2013
Q3 | $814K | Buy |
149,993
+19,354
| +15% | +$93K | ﹤0.01% | 3384 |
|
|
2013
Q2 | $530K | Buy |
+130,639
| New | +$613K | ﹤0.01% | 3585 |
|
Other funds holding BDSI
JP Morgan Chase's BDSI Position: Q1 2022 in Review
JP Morgan Chase sold out of BioDelivery Sciences International, Inc. (BDSI) in Q1 2022, closing a stake of 572,083 shares — an estimated $1.77M sold.
JP Morgan Chase first reported a position in BDSI in Q2 2013 and held it in 30 quarters. The position peaked at $3.85M in Q1 2019. 2 funds tracked by Wall St. Rank hold BDSI as of Q1 2022.
- JP Morgan Chase reported no remaining BioDelivery Sciences International, Inc. position as of Q1 2022 after selling out during the quarter.
- JP Morgan Chase sold 572,083 BioDelivery Sciences International, Inc. shares in Q1 2022, an estimated $1.77M.
- JP Morgan Chase first reported a position in BioDelivery Sciences International, Inc. in Q2 2013 and held it in 30 quarters.
- JP Morgan Chase's BioDelivery Sciences International, Inc. position peaked at $3.85M in Q1 2019.
- 2 funds tracked by Wall St. Rank held BioDelivery Sciences International, Inc. as of Q1 2022.
Based on JP Morgan Chase's 13F filing for Q1 2022, filed 11 May 2022.